1911 related articles for article (PubMed ID: 31582403)
21. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
22. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
[TBL] [Abstract][Full Text] [Related]
23. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
[No Abstract] [Full Text] [Related]
24. Methyltransferase like 3 enhances pinin mRNA stability through N
He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
[TBL] [Abstract][Full Text] [Related]
25. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.
Lin S; Choe J; Du P; Triboulet R; Gregory RI
Mol Cell; 2016 May; 62(3):335-345. PubMed ID: 27117702
[TBL] [Abstract][Full Text] [Related]
26. METTL3-mediated m
Ji G; Wang X; Xi H
Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387
[TBL] [Abstract][Full Text] [Related]
27. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway.
Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N
Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203
[TBL] [Abstract][Full Text] [Related]
29. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
30. m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.
Xu W; Lai Y; Pan Y; Tan M; Ma Y; Sheng H; Wang J
Cell Death Dis; 2022 Aug; 13(8):715. PubMed ID: 35977935
[TBL] [Abstract][Full Text] [Related]
31. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
32. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
Liao L; He Y; Li SJ; Zhang GG; Yu W; Yang J; Huang ZJ; Zheng CC; He QY; Li Y; Li B
Cancer Res; 2022 Jul; 82(13):2444-2457. PubMed ID: 35507004
[TBL] [Abstract][Full Text] [Related]
33. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
34. RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.
Zheng L; Chen X; Yin Q; Gu J; Chen J; Chen M; Zhang Y; Dong M; Jiang H; Yin N; Chen H; Li X
Biochem Biophys Res Commun; 2022 Dec; 635():120-127. PubMed ID: 36265285
[TBL] [Abstract][Full Text] [Related]
35. N
Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
[TBL] [Abstract][Full Text] [Related]
36. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
[TBL] [Abstract][Full Text] [Related]
37. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
Zhang Y; Liu S; Zhao T; Dang C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
[TBL] [Abstract][Full Text] [Related]
38. METTL3/METTL14 Transactivation and m
Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
[TBL] [Abstract][Full Text] [Related]
39. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
[TBL] [Abstract][Full Text] [Related]
40. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
